Advertisement
Screener

Korro Bio, Inc. (KRRO) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Korro Bio, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Korro Bio, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $78.56M went out.
  • Fiscal year ended 2025-12-31: from investing, $43.99M came in.
  • Fiscal year ended 2025-12-31: from financing, $685.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $33.82M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtNew shares soldOtherNot split outChange in cash
2025-12-31-$78.56M$43.99M$685.00K-$33.82M
2024-12-31-$60.07M-$123.35M$1.97M$67.39M*-$114.07M
2023-12-31-$67.28M$11.16M$117.25M-$2.00K$70.51M*$131.64M
2022-12-31-$53.65M$11.06M$0.00-$44.00K-$42.57M
2021-12-31-$76.06M-$66.13M$1.30M-$140.83M
2020-12-31-$45.19M$10.40M$15.00M$1.54M$40.14M*$21.90M
2019-12-31$34.22M-$18.26M$80.06M$61.95M*$157.97M
2018-12-31-$17.02M-$436.00K$73.00K$41.64M*$24.25M
2017-12-31-$14.61M-$1.86M$27.00K$27.95M*$11.50M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldOtherNot split outChange in cash
2026-06-30-$16.99M*-$17.90M*-$2.90M*
2026-03-31-$16.07M-$32.24M$83.15M$5.06M*$39.87M
2025-12-31-$17.70M*$14.92M*$380.00K*
2025-09-30-$17.18M*$7.60M*$128.00K*
2025-06-30-$19.23M*-$11.30M*$0.00*
2025-03-31-$24.45M$32.78M$0.00$8.50M
2024-12-31-$7.50M*-$2.77M*$931.00K*$0.00*
2024-09-30-$16.09M*-$12.58M*$728.00K*$0.00*
2024-06-30-$14.59M*-$102.39M*$172.00K*$0.00*$67.38M*
2024-03-31-$21.89M-$5.61M$139.00K$0.00-$27.36M
2023-12-31-$21.11M*-$1.66M*$117.25M*$2.63M*$24.71M*
2023-09-30-$11.77M*$754.00K*$0.00*$0.00*-$2.41M*
2023-06-30-$14.71M*-$3.42M*-$11.67M*-$1.00K*-$76.00K*
2023-03-31-$19.69M$15.49M$51.00K-$150.00K$45.50M*$41.20M
2022-12-31-$11.03M*$4.49M*-$60.00K*
2022-09-30-$11.80M*$13.21M*$0.00*-$1.00K*
2022-06-30-$13.48M*$6.02M*$0.00*$0.00*
2022-03-31-$17.34M-$12.66M$0.00$61.00K-$29.80M
2021-12-31-$17.89M*-$14.65M*$110.00K*
2021-09-30-$15.02M*-$8.41M*$288.00K*
2021-06-30-$17.67M*-$16.86M*$328.00K*
2021-03-31-$25.47M-$26.21M$572.00K-$51.11M
2020-12-31-$14.83M*-$4.43M*$15.38M*
2020-09-30-$10.73M*-$1.02M*$462.00K*$40.14M*
2020-06-30-$10.26M*$2.17M*$391.00K*
2020-03-31-$9.36M$13.69M$309.00K$4.63M
2019-12-31-$29.74M*$5.43M*$79.74M*$2.46M*
2019-09-30$74.58M*$4.64M*$161.00K*$59.23M*
2019-06-30-$4.47M*$7.01M*$88.00K*
2019-03-31-$6.15M-$35.34M$76.00K-$41.15M
2018-12-31-$4.72M*-$239.00K*$3.00K*$34.87M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atrium Therapeutics, Inc. (RNA)United States$0.140B
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Annexon, Inc. (ANNX)United States$0.147B-4.22
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88